NEW YORK CITY, NY / ACCESS Newswire / March 13, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Encompass Health Corporation ("Encompass" or "the Company") (NYSE:EHC). Investors who purchased Encompass securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EHC.
Encompass Investigation Details
On July 15, 2025, citing federal data and inspection reports, The New York Times published an article alleging that for-profit hospitals run by Encompass perform below average on key safety measures. The article reported that "Encompass owns many of the rehabs with worse rates of potentially preventable, unplanned readmissions to general hospitals" including 34 facilities which "Medicare rated as having statistically significantly worse rates of potentially preventable readmissions." The article further described a number of "alarming mistakes" leading to fatalities of patients in the care of Encompass-owned facilities. Following publication of the article, Encompass’s stock price fell $12.39 per share, or 10.35%, to close at $107.28 on July 15, 2025.
What’s Next for Encompass Investors?
If you are aware of any facts relating to this investigation or purchased Encompass securities, you can assist this investigation by visiting the firm’s site: bgandg.com/EHC. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Encompass Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Encompass Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | info@bgandg.com
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
COMTEX_475191669/2457/2026-03-13T11:03:28